Antonio Boza‐Serrano

3.4k total citations · 2 hit papers
28 papers, 2.1k citations indexed

About

Antonio Boza‐Serrano is a scholar working on Immunology, Neurology and Neurology. According to data from OpenAlex, Antonio Boza‐Serrano has authored 28 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Neurology and 7 papers in Neurology. Recurrent topics in Antonio Boza‐Serrano's work include Neuroinflammation and Neurodegeneration Mechanisms (14 papers), Galectins and Cancer Biology (11 papers) and Alzheimer's disease research and treatments (6 papers). Antonio Boza‐Serrano is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (14 papers), Galectins and Cancer Biology (11 papers) and Alzheimer's disease research and treatments (6 papers). Antonio Boza‐Serrano collaborates with scholars based in Sweden, Spain and United States. Antonio Boza‐Serrano's co-authors include Tomas Deierborg, Yiyi Yang, Agnes Paulus, Sara Bachiller, Itzia Jiménez-Ferrer, Maria Swanberg, José L. Venero, Martina Svensson, Juan García‐Revilla and Miguel Ángel Burguillos and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Antonio Boza‐Serrano

28 papers receiving 2.0k citations

Hit Papers

Microglia in Neurological Diseases: A Road Map to Brain-D... 2018 2026 2020 2023 2018 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
    2018 540 citations Sara Bachiller, Itzia Jiménez-Ferrer et al. Frontiers in Cellular Neuroscience profile →
  2. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
    2022 145 citations Rosalía Fernández‐Calle, Sabine C Konings et al. Molecular Neurodegeneration profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Boza‐Serrano Sweden 18 830 767 596 471 327 28 2.1k
Miguel Ángel Burguillos Spain 21 800 1.0× 828 1.1× 701 1.2× 302 0.6× 227 0.7× 33 2.1k
Pengfei Xu China 22 1.1k 1.3× 889 1.2× 621 1.0× 271 0.6× 253 0.8× 43 2.4k
Fabio Buttari Italy 36 1.1k 1.4× 778 1.0× 496 0.8× 463 1.0× 521 1.6× 107 3.4k
Mithilesh Kumar Jha South Korea 29 880 1.1× 1.0k 1.4× 554 0.9× 616 1.3× 338 1.0× 54 2.9k
Andrew D. Greenhalgh Canada 22 1.3k 1.6× 676 0.9× 797 1.3× 270 0.6× 310 0.9× 34 2.7k
Šárka Lehtonen Finland 24 629 0.8× 818 1.1× 285 0.5× 450 1.0× 318 1.0× 59 2.1k
Antonietta Gentile Italy 29 909 1.1× 683 0.9× 321 0.5× 291 0.6× 249 0.8× 61 2.4k
Jae‐Hong Kim South Korea 19 841 1.0× 435 0.6× 285 0.5× 333 0.7× 439 1.3× 37 1.8k
Dale B. Bosco United States 24 1.3k 1.6× 532 0.7× 552 0.9× 323 0.7× 194 0.6× 40 2.2k
Nikolett Lénárt Hungary 17 763 0.9× 667 0.9× 387 0.6× 294 0.6× 155 0.5× 27 1.6k

Countries citing papers authored by Antonio Boza‐Serrano

Since Specialization
Citations

This map shows the geographic impact of Antonio Boza‐Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Boza‐Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Boza‐Serrano more than expected).

Fields of papers citing papers by Antonio Boza‐Serrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Boza‐Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Boza‐Serrano. The network helps show where Antonio Boza‐Serrano may publish in the future.

Co-authorship network of co-authors of Antonio Boza‐Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Boza‐Serrano. A scholar is included among the top collaborators of Antonio Boza‐Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Boza‐Serrano. Antonio Boza‐Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Revilla, Juan, Antonio Boza‐Serrano, Devkee M. Vadukul, et al.. (2023). Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease. Acta Neuropathologica. 146(1). 51–75. 18 indexed citations
2.
Arroyo‐García, Luis Enrique, Sara Bachiller, Rocío Ruiz, et al.. (2023). Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease. Translational Neurodegeneration. 12(1). 6–6. 13 indexed citations
3.
Borrego‐Écija, Sergi, Anna Antonell, Albert Lladó, et al.. (2023). Galectin‐3 is upregulated in frontotemporal dementia patients with subtype specificity. Alzheimer s & Dementia. 20(3). 1515–1526. 8 indexed citations
4.
Boza‐Serrano, Antonio, Agathe Vrillon, Karolina Minta, et al.. (2022). Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease. Acta Neuropathologica. 144(5). 843–859. 33 indexed citations
5.
Bachiller, Sara, Isabel Hidalgo, Antonio Boza‐Serrano, et al.. (2022). Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner. Journal of Neuroinflammation. 19(1). 151–151. 19 indexed citations
6.
Fernández‐Calle, Rosalía, Sabine C Konings, Javier Frontiñán-Rubio, et al.. (2022). APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases. Molecular Neurodegeneration. 17(1). 62–62. 145 indexed citations breakdown →
7.
Paulus, Agnes, Anders Engdahl, Yiyi Yang, et al.. (2021). Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease. International Journal of Molecular Sciences. 22(7). 3430–3430. 7 indexed citations
8.
Bruzelius, Andreas, et al.. (2020). The human bone marrow harbors a CD45− CD11B+ cell progenitor permitting rapid microglia-like cell derivative approaches. Stem Cells Translational Medicine. 10(4). 582–597. 5 indexed citations
9.
Jiménez-Ferrer, Itzia, Michael Jewett, Antonio Boza‐Serrano, et al.. (2020). The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease. Brain Behavior and Immunity. 91. 369–382. 16 indexed citations
10.
García‐Revilla, Juan, Tomas Deierborg, José L. Venero, & Antonio Boza‐Serrano. (2020). Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider. Frontiers in Immunology. 11. 2069–2069. 72 indexed citations
11.
Gredal, Hanne, Antonio Boza‐Serrano, Tomas Deierborg, et al.. (2019). Diagnosis and long‐term outcome in dogs with acute onset intracranial signs. Journal of Small Animal Practice. 61(2). 101–109. 4 indexed citations
12.
Yang, Yiyi, Antonio Boza‐Serrano, Christopher J.R. Dunning, et al.. (2018). Inflammation leads to distinct populations of extracellular vesicles from microglia. Journal of Neuroinflammation. 15(1). 168–168. 141 indexed citations
13.
Bachiller, Sara, Itzia Jiménez-Ferrer, Agnes Paulus, et al.. (2018). Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Frontiers in Cellular Neuroscience. 12. 488–488. 540 indexed citations breakdown →
14.
Espinosa‐Oliva, Ana M., Irene García-Domínguez, Antonio Boza‐Serrano, et al.. (2018). Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease. Frontiers in Cellular Neuroscience. 12. 440–440. 53 indexed citations
15.
Boza‐Serrano, Antonio, Yiyi Yang, Agnes Paulus, & Tomas Deierborg. (2018). Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD. Scientific Reports. 8(1). 1550–1550. 94 indexed citations
16.
Clausen, Bettina Hjelm, Nellie Anne Martin, Martina Svensson, et al.. (2017). Fumarate decreases edema volume and improves functional outcome after experimental stroke. Experimental Neurology. 295. 144–154. 42 indexed citations
17.
Svensson, Martina, et al.. (2016). Forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia. Neurobiology of Stress. 5. 8–18. 113 indexed citations
18.
Djelloul, Mehdi, Staffan Holmqvist, Antonio Boza‐Serrano, et al.. (2015). Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models. Stem Cell Reports. 5(2). 174–184. 105 indexed citations
19.
Burguillos, Miguel Ángel, Martina Svensson, Tim Schulte, et al.. (2015). Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. Cell Reports. 10(9). 1626–1638. 278 indexed citations
20.
Macher, Hada C., J.J. Egea-Guerrero, J. Revuelto‐Rey, et al.. (2012). Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. Clinica Chimica Acta. 414. 12–17. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Ángel Burguillos Breakdown of academic impact, for papers by Pengfei Xu Breakdown of academic impact, for papers by Fabio Buttari Breakdown of academic impact, for papers by Mithilesh Kumar Jha Breakdown of academic impact, for papers by Andrew D. Greenhalgh Breakdown of academic impact, for papers by Šárka Lehtonen Breakdown of academic impact, for papers by Antonietta Gentile Breakdown of academic impact, for papers by Jae‐Hong Kim Breakdown of academic impact, for papers by Dale B. Bosco Breakdown of academic impact, for papers by Nikolett Lénárt
Rankless by CCL
2026